Vestmark Advisory Solutions’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.6M | Buy |
1,294,186
+612,760
| +90% | +$760K | 0.02% | 411 |
|
|
2025
Q1 | $804K | Sell |
681,426
-215,632
| -24% | -$254K | 0.02% | 439 |
|
|
2024
Q4 | $2M | Buy |
897,058
+276,351
| +45% | +$617K | 0.07% | 260 |
|
|
2024
Q3 | $1.06M | Sell |
620,707
-90,143
| -13% | -$153K | 0.04% | 296 |
|
|
2024
Q2 | $974K | Sell |
710,850
-224,439
| -24% | -$307K | 0.04% | 316 |
|
|
2024
Q1 | $3.51M | Buy |
935,289
+440,499
| +89% | +$1.65M | 0.15% | 160 |
|
|
2023
Q4 | $4.85M | Buy |
+494,790
| New | +$4.85M | 0.25% | 97 |
|